Evidence for Human Lifespan Limit Contested

Five groups of scientists criticize a widely publicized Nature paper from 2016 suggesting that humans can only live up to 115 years.

Written byDiana Kwon
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ISTOCK, PRAETORIANPHOTOLast October, a paper published in Nature made a big splash with its claim that human longevity was limited to 115 years. Although the study made headlines in most of the major news outlets, it sparked a heated debate among scientists—not everyone was sold on the authors’ conclusions. Five groups of researchers have now published a series of formal rebuttals that were published today (June 28) in Nature Communications Arising.

In the 2016 study, Jan Vijg, a molecular geneticist at the Albert Einstein College of Medicine, and colleagues analyzed global demographic data over the last century and demonstrated that since the mid-1990s, peak age plateaued at around 115 years. Based on these results, the authors concluded that humans had natural age limit at 115, and that the probability of surviving to over the age of 125 was less than 1 in 10,000.

“It’s an extreme claim that they make that there is a limit to human lifespan, and I think an extreme claim deserves extreme scrutiny,” says Maarten Pieter Rozing, a professor at the University of Copenhagen’s Center for Healthy Aging, who co-authored a rebuttal. “There is an alternative explanation, which is that [maximum age] ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies